Stock Events

Stock Events

Immunotech Laboratories

$0.000200

4

+$0.00+0%Wednesday 17:13

Statistics

Day High

0.0001

Day Low

0.0001

52W High

0.0002

52W Low

0.0001

Volume

244,208

Avg. Volume

2,621

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets drugs for life-threatening infectious diseases, including HIV/AIDS, a key area of focus for Immunotech Laboratories.

Merck & Co., Inc. is a global healthcare company that produces medicines, vaccines, biologic therapies, and animal health products, competing in the infectious disease space with Immunotech.

Johnson & Johnson

Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the healthcare field, including treatments for infectious diseases.

Pfizer is a research-based biopharmaceutical company with a wide range of products including vaccines and treatments for infectious diseases, making it a competitor.

Abbott Laboratories

Abbott Laboratories operates in various segments, including diagnostics and medical devices, but its work in diagnostics for infectious diseases places it in competition with Immunotech.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose focus on developing treatments for serious diseases, including HIV/AIDS, pits it against Immunotech Laboratories.

Amgen is a biotechnology company focusing on areas such as oncology/hematology, cardiovascular disease, and inflammation, but its work in biologics can indirectly compete with Immunotech's approach.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious diseases, including infectious diseases, making it a competitor.

Vertex Pharmaceuticals

Vertex Pharmaceuticals is known for its work in treating cystic fibrosis but its expansion into other serious diseases including viral infections competes with Immunotech's focus areas.

Novartis AG is a global healthcare company that researches, develops, manufactures, and markets a wide range of healthcare products, including treatments for infectious diseases, competing with Immunotech.

About

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.

Show More

CEO

Jennifer L. Bath

Employees

4

Country

United States

ISIN

US45254F2039

Listings

0 Comments

Share your thoughts

FAQs

What is Immunotech Laboratories stock price today?▼

The current price of IMMB is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Immunotech Laboratories stock price performance more closely on the chart.

What is Immunotech Laboratories stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Immunotech Laboratories stocks are traded under the ticker IMMB.

How many employees does Immunotech Laboratories have?▼

As of November 1, 2026, the company has 4 employees.

In which sector is Immunotech Laboratories located?▼

Immunotech Laboratories operates in the Health & Wellness sector.

When did Immunotech Laboratories complete a stock split?▼

Immunotech Laboratories has not had any recent stock splits.

Where is Immunotech Laboratories headquartered?▼

Immunotech Laboratories is headquartered in Monrovia, United States.